Analysis | Metabolite Name | Measured Value | Units | subject type |
---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 49748 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 63762 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 64028 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 72728 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 80227 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 86305 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 102939 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 117823 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 120927 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 121645 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 134263 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 142402 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 146191 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 149421 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 185904 | Peak area | Mild disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 198456 | Peak area | Healthy control |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 202700 | Peak area | Severe disease |
Reversed phase NEGATIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M-H)- | 220274 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 8083 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 10543 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 14751 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 16330 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 16959 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 20064 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 20788 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 23490 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 23959 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 28305 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 32546 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 32741 | Peak area | Mild disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 36965 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 39283 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 39367 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 39539 | Peak area | Severe disease |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | 41640 | Peak area | Healthy control |
Reversed phase POSITIVE ION MODE | XANTHOSINE (CAS# 146-80-5); (M+H)+ | Peak area | Healthy control |